"Are you worried?" Song Zimo asked.
Yang Ping was silent for a mont: "Worried, but more worried about if we know the problem exists but don’t solve it, patients facing treatnt failure in the future would be sothing we couldn’t face."
Everyone nodded, that’s Professor Yang, always putting patient safety and technical perfection first, no matter the cost. He is a technical fanatic.
"President Huang said he will handle the production modifications," Song Zimo said, "The training updates need to be led by us, and as for the clinical protocol revisions..." he paused, "we might need to temporarily slow down the intake of new patients."
"That pancreatic cancer patient can’t wait."
"We’ll set up an ergency pathway, use the current protocol for an initial treatnt, and expedite the developnt of new vectors. This is the best balance at the mont."
Yang Ping looked at Lu Xiaolu and suddenly asked, "How did you think of inviting Academician Chen?"
Lu Xiaolu candidly replied, "Though I work across multiple fields like tumor and immunity, in terms of vector virus, Professor Chen is currently leading worldwide. I often discuss academic issues with him, and when he shared new results with , it suddenly enlightened , so I hastily invited him here. Thank you, Teacher Chen."
Academician Chen waved his hand: "Not at all, I’ve researched vector virus for half my life, and now it finally serves a purpose."
"There’s a Chinese scientist nad Wu Changde you should be aware of. He approached , hoping I would join his team to indirectly replicate your technology."
Yang Ping smiled: "Don’t worry, it’s futile. He is too naive, thinking he can replicate with open literature, K compound samples, and stealing a bit of technology. He doesn’t understand K Therapy at all; even if I gave him all the data now, he wouldn’t be able to replicate it."
A talent is indeed a talent, and Professor Chen couldn’t help but admire Yang Ping.
...
Nine o’clock in the morning, Sanbo International dical Education College.
Yang Ping stood on the podium, facing thirty-seven international trainees, with a serious expression. Behind him, a large screen displayed adenovirus pre-existing immunity data confird last night.
"Everyone, today’s course content needs an urgent adjustnt." Yang Ping said straightforwardly, "We discovered a previously overlooked major issue: adenovirus serotype pre-existing immunity may severely affect the efficacy of K Therapy. This ans, before upgrading the K compound, every case you implent after returning to your country must first undergo antibody screening; this will help increase the treatnt rate."
The classroom was in an uproar, with trainees looking at each other, this was completely beyond the previous training content.
"Professor, what about patients who test positive in screening?" Griffin asked.
"That’s exactly the new protocol we’re discussing today," Yang Ping brought up the hybrid vector library design from Academician Chen’s team, "If patients have high-titer antibodies to a certain adenovirus, we switch to vectors of other serotypes. But this requires production reserves of multiple vector versions and a more complex treatnt protocol formulation process."
German trainee Hans raised his hand: "This will be very difficult in practical operation. The European Center currently only has one compound, and if multiple versions are reserved, supply chain, storage, and managent costs will greatly increase."
"Indeed," Yang Ping admitted, "so this is a dilemma: either maintain the status quo, which may leave so patients without effective treatnt, or upgrade the K compound and related systems, facing huge implentation challenges. I’d like to hear your thoughts."
This question was thrown to the future implenters, and the trainees engaged in intense discussions.
Indian trainee Rajiv said: "In India, dical resources are already tight, multi-version reserves are nearly impossible. Maybe we can screen patients and only treat those who are antibody-negative."
"But what about those who are antibody-positive?" Brazilian trainee Carlos opposed, "They also have the right to survive."
"Perhaps we could develop a pre-treatnt plan to remove antibodies," an Arican trainee suggested, "using plasma exchange or immunoadsorption to lower antibody titers before treatnt."
"That would increase treatnt complexity and risk, and the effect is uncertain."
The discussion lasted for an hour, Yang Ping just listened, without making judgnts, guiding trainees to think, debate, and find their own solutions.
Finally, Griffin stood up: "Professor, I have an idea, perhaps we can establish regional shared vector libraries. For instance, the United States and Canada can share a multi-version reserve center, adjusting usage based on patient conditions, though logistics would be complex, it’s more feasible than each country preparing independently."
"What about the regulatory approvals of different countries?" Hans asked.
"That’s exactly the issue that needs coordination from various national health departnts," Carlos said, "But if we, the dical community, jointly voice out, emphasizing this is for patient benefit, it might drive policy breakthroughs."
This suggestion gained the approval of most trainees. dical issues ultimately require dical workers to proactively push for system changes.
After class, Yang Ping called Griffin aside: "Your idea is bold, but it does have feasibility. Would you be willing to take the lead in promoting North Arican regional collaboration after returning to your country?"
Griffin was slightly taken aback, then solemnly nodded: "I’m willing to try, even if it’s fraught with difficulties, it’s worth the effort for the patients."
In the afternoon, Huang Jiacai ca to the training camp, having listened to the morning discussion recording, he was thoughtful.
"The level of thinking of these trainees is higher than we anticipated," he said to Yang Ping, "They not only want to learn the technology but are also considering system optimization and regional collaboration."
"Because they co from the frontline and understand the practical difficulties best," Yang Ping said, "Perhaps we should adjust the training model, not only teaching them how to do things but also inspiring them to think about how to do it better. The establishnt of the K Therapy model itself is an attempt and should involve their participation, making them the main body, continuously reforming."
User Comments
0 comments from readers